Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05851196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Forgotten Role of Back Muscle Characteristics to Tailor Exercise Therapy for Recurrent Non-specific Low Back Pain

Study acronym: Back-to-Back
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 8 words
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2023 to Jan 15, 2024
    • Site details revised at 2 of 2 sites
    v5
  3. Start date: Aug 1, 2023 to Oct 1, 2023v4
  4. Start date: Jul 1, 2023 to Aug 1, 2023
    • Primary endpoints: 25 to 23
    v3
  5. Start date: May 1, 2023 to Jul 1, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with non-specific low back pain will be compared to healthy, age- and sex-matched controls to determine the most discriminating back muscle characteristics and to delineate possible phenotypes of patients with non-specific low back pain showing impaired proprioceptive postural control. Additionally, the group of patients with non-specific low back pain will receive a 16-week, high-load proprioceptive training program. The effects of this training program on the different back muscle characteristics and proprioceptive postural control will be evaluated.
Trial Details
NCT Number NCT05851196
Lead Sponsor Hasselt University
Collaborators: KU Leuven
Conditions
(from sponsor)		 Low Back Pain, Back Pain Lower Back Chronic
Related terms Low Back Pain
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov